China’s venture capital market is the second-largest globally, boasting cutting-edge innovation and growth across technology, healthcare, renewable energy and more. With more than $1 billion allocated to venture funds in China by experienced investors such as RisCura, the country has consistently demonstrated a strong track record of delivering competitive returns. China’s shift from ‘made in China’ to ‘invented in China’ … Continue reading Altvest opens China’s venture capital market to SA investors